Koninklijke DSM N.V. RDSMY OTC

Koninklijke DSM N.V. (RDSMY) generated $1.43B in operating cash flow for fiscal year 2021. After capital expenditures of $577M, free cash flow was $850M.

Free cash flow margin was 9.2% of revenue. Cash conversion ratio was 0.85x, suggesting some earnings are non-cash.

The company returned $266M in dividends and $165M in share buybacks to shareholders during the period.

Criteria supported by this page:

• HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
• MOAT (39/100, Fail) — limited free cash flow weakens the competitive position
• INCOME (45/100) — Cash conversion ratio was 0.85x suggests some earnings are non-cash items

Overall SharesGrow Score: 68/100 with 4/7 criteria passed.